相关实验视频

Updated: Sep 20, 2025

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

通过外科手术和皮肤透视双管架辅助设备支持的患者的机构比较

Jessica S Clothier¹, Serge Kobsa¹, Markian Bojko¹

¹Division of Cardiac Surgery, University of Southern California Keck School of Medicine, Los Angeles, California.

The Annals of thoracic surgery

|May 23, 2025

概括

透皮双心室辅助器件 (pBiVADs) 为外科手术BiVADs (sBiVADs) 提供了一个不那么侵入性的替代方案,需要更少的输血和手术室返回. 两组的30天生存率在两组之间是可比的.

科学领域:

心血管医学心血管医学
医疗器械医疗器械
手术创新在外科创新.

背景情况:

手术双心室辅助器件 (sBiVADs) 是已确立的终端心力衰竭治疗方法.
穿皮双心室辅助器件 (pBiVADs) 是一种较新的,较少侵入性的方法,研究有限.
这项研究比较了大量患者队列中sBiVADs和pBiVADs之间的结果.

研究的目的:

为了比较接受手术双心室辅助器件 (sBiVADs) 和穿皮双心室辅助器件 (pBiVADs) 的患者的临床结果.
评估pBiVADs的安全性和有效性,作为通往先进疗法或恢复的桥梁.

主要方法:

从2014年到2023年连续使用双心室辅助器件 (BiVAD) 的46名患者的回顾性审查.
对患有sBiVADs (n=27) 和pBiVADs (n=19) 的患者进行比较,包括Impella设备和皮肤透氧右心室辅助设备.
对手术内和术后输血需求,返回手术室和30天生存率的分析.

主要成果:

在sBiVAD和pBiVAD组之间没有观察到手术前风险因素的显著差异.
患有pBiVAD的患者需要的血液产品输血 (红细胞,新鲜冷血,血小板) 在手术期间和手术后显著减少.
pBiVAD患者经历的意外返回手术室较少,30天生存率相似 (56.6%与36.8%).

结论:

穿皮双心室辅助器件 (pBiVADs) 是先进心力衰竭患者的不那么侵入性和可行的选择.
pBiVADs作为一个有效的桥梁移植,耐用的左心室辅助装置治疗,或潜在的恢复.
这些发现支持了微创循环支持器件在管理复杂心脏病的日益增长的作用.

更多相关视频

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

相关概念视频

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.